← Back to Search

Transcutaneous CO2 monitoring for Ultrasonographic Assessment of Diaphragm in Pediatric Patients

N/A

Waitlist Available

Led By Reshma Amin, MD

Research Sponsored by The Hospital for Sick Children

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a portable device that measures carbon dioxide levels in children with neuromuscular disorders while they sleep at home. The goal is to help doctors diagnose and treat breathing problems more quickly and efficiently.

Eligible Conditions

Ultrasonographic Assessment of Diaphragm in Pediatric Patients
Sleep Apnea
Apnea
Neuromuscular Disease
Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

a) Agreement of tcCO2 monitoring when worn in the ambulatory, at home, setting compared to tcCO2 recorded during a PSG in a hospital based sleep laboratory for diagnosis of nocturnal hypoventilation.